Tumor growth rate provides useful information to evaluate Sorafenib and everolimus treatment in metastatic renal cell carcinoma patients: An integrated analysis of the TARGET and RECORD phase 3 trial data

Charles Ferté, Serge Koscielny, Laurence Albiges, Laurence Rocher, Jean Charles Soria, Roberto Iacovelli, Yohann Loriot, Karim Fizazi, Bernard Escudier

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Tumor growth rate provides useful information to evaluate Sorafenib and everolimus treatment in metastatic renal cell carcinoma patients: An integrated analysis of the TARGET and RECORD phase 3 trial data'. Together they form a unique fingerprint.

Medicine & Life Sciences